Advanced model-based control strategies for the intensification of upstream and downstream processing in mAb production

Author:

Papathanasiou Maria M.12ORCID,Quiroga-Campano Ana L.1,Steinebach Fabian3,Elviro Montaña1,Mantalaris Athanasios1,Pistikopoulos Efstratios N.2

Affiliation:

1. Dept. of Chemical Engineering; Centre for Process Systems Engineering (CPSE), Imperial College London; London SW7 2AZ U.K

2. Artie McFerrin Department of Chemical Engineering; Texas A&M University, College Station; TX 77843

3. Institute for Chemical and Bioengineering; ETH Zurich; olfgang-Pauli-Str. 10/HCI F 129, W Zurich CH-8093 Switzerland

Publisher

Wiley

Subject

Biotechnology

Reference65 articles.

1. Research , T. M. 2012 http://www.transparencymarketresearch.com/monoclonal-antibodies.html

2. Developing the Nation's Biosimilars Program;Kozlowski;N Engl J Med.,2011

3. Innovation and competition: Will biosimilars succeed? The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety;Blackstone;Biotechnol Healthcare.,2012

4. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies;Xenopoulos;J Biotechnol.,2015

5. The business impact of an integrated continuous biomanufacturing platform for recombinant protein production;Walther;J Biotechnol.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3